Nanox.AI is a suite of FDA-cleared artificial intelligence solutions designed to analyze routine medical CT scans and identify early signs of chronic diseases. By leveraging advanced AI algorithms, Nanox.AI assists clinicians in detecting asymptomatic, undiagnosed conditions, facilitating earlier diagnosis and preventive care. This proactive approach aims to improve patient outcomes and reduce the burden on healthcare systems. Key Features and Functionality: - HealthCCSng Cardiac Solution: Automatically detects coronary artery calcification (CAC from routine chest CT scans, aiding in the identification of patients at risk for coronary artery disease without the need for dedicated imaging. - HealthOST Bone Solution: Identifies vertebral compression fractures and low bone mineral density in chest and abdominal CT scans, assisting in the early detection of osteoporosis. - HealthFLD Fatty Liver Solution: Utilizes AI algorithms to detect signs of fatty liver disease in routine CT scans, enabling early intervention strategies. Primary Value and Problem Solved: Nanox.AI addresses the challenge of undiagnosed chronic conditions by extracting actionable insights from existing medical imaging data. Its AI-driven analysis enables healthcare providers to identify at-risk patients earlier in their disease progression, allowing for timely interventions and personalized preventive care plans. This not only enhances patient health outcomes but also optimizes healthcare resources by reducing the incidence of advanced disease complications.